![Diabetes / Peptide hormones / Recombinant proteins / Eli Lilly and Company / RTT / Insulin aspart / Insulin / Diabetes management / Diabetes mellitus type 1 / Glycated hemoglobin / Hyperglycemia / Insulin degludec Diabetes / Peptide hormones / Recombinant proteins / Eli Lilly and Company / RTT / Insulin aspart / Insulin / Diabetes management / Diabetes mellitus type 1 / Glycated hemoglobin / Hyperglycemia / Insulin degludec](https://www.pdfsearch.io/img/08dc901a195b4b27a5dbd6d0b8ab40f3.jpg) Date: 2016-08-18 19:09:23Diabetes Peptide hormones Recombinant proteins Eli Lilly and Company RTT Insulin aspart Insulin Diabetes management Diabetes mellitus type 1 Glycated hemoglobin Hyperglycemia Insulin degludec | | This material is intended for Canadian media only. Faster-acting insulin aspart showed a statistically significant reduction in HbA1c in type 1 diabetes and a comparable HbA1c reduction in type 2 diabetes versus NovoRapAdd to Reading ListSource URL: www.novonordisk.caDownload Document from Source Website File Size: 213,78 KBShare Document on Facebook
|